Trial reportPloS one2026
A randomised crossover trial comparing photobiomodulation therapy with other recovery strategies in CrossFit athletes.
Trial report in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06628609 (Post-exercise Therapeutic Modalities on Functional Performance, Muscle Damage and Oxidative Stress of CrossFit® Athletes), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Post-exercise Therapeutic Modalities on Functional Performance, Muscle Damage and Oxidative Stress of CrossFit® Athletes
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study compared the effects of different therapeutic modalities on recovery following the workout of the day (WOD) in CrossFit athletes, focusing on reducing muscle damage and improving functional performance.
methodsIn a randomised, controlled, crossover design, twelve CrossFit athletes underwent four post-WOD recovery interventions across four weeks: passive recovery (PR), intermittent pneumatic compression (IPC), extracorporeal shock wave therapy (ESWT), and photobiomodulation therapy combined with a static magnetic field (PBMT-sMF). Assessments were conducted at baseline, and at 1, 24, and 48 hours post-WOD. The primary outcome was vertical jump performance (countermovement jump [CMJ] height) at 1-hour post-WOD; secondary outcomes included lactate dehydrogenase (LDH) levels, superoxide dismutase (SOD) and catalase (CAT) activity, thiobarbituric acid reactive substances (TBARS), carbonylated proteins, perceived exertion, and intervention satisfaction.
resultsThere was no significant difference between interventions in CMJ height at 1-hour post-WOD. In contrast, PBMT-sMF outperformed the other interventions in the secondary outcomes. PBMT-sMF significantly improved CMJ height at 24 and 48 hours compared with PR (p < 0.05) and led to greater reductions in LDH at both time points (p < 0.05 and p < 0.001, respectively). PBMT-sMF also produced lower TBARS and carbonylated protein levels, with higher CAT and SOD activities at 24 and 48 hours (p < 0.05 and p < 0.0001, respectively). CAT and SOD activities were also significantly elevated at 1 hour post-WOD compared with PR (p < 0.05).
conclusionsPBMT-sMF may be an effective recovery strategy for CrossFit athletes, with its benefits possibly related to the modulation of oxidative stress as an underlying mechanism.
trial registrationTrial registration number: NCT06628609.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.